Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1982 Oct;50(1):231–237.

Radiometric ligand binding assay for C-reactive protein. Complexed C-reactive protein is not detectable in acute phase serum.

F C De Beer, B Shine, M B Pepys
PMCID: PMC1536841  PMID: 7172508

Abstract

A radiometric ligand binding assay for human C-reactive protein (CRP) was established using pneumococcal C polysaccharide (CPS) coupled to magnetizable cellulose particles as the solid phase ligand. Competition for binding to the solid phase between 125I-CRP and unlabelled CRP permitted detection of 30 micrograms/l of CRP and the precise assay of concentrations up to 3000 micrograms/l. Identical results were obtained when the assay was used to quantitate isolated pure CRP and pure CRP added to normal human serum. However in vitro addition of known ligands for CRP to acute phase serum resulted in lowering of the apparent CRP concentration in this assay and addition of as little as 1 microgram/l of free CPS or 1 mg/l of lecithin was demonstrable in this way. A combination of the ligand binding assay and the standard electroimmunoassay for CRP was therefore used to test acute phase sera for the presence of CRP complexed in vitro. No evidence of complexed CRP was detected among sera containing between 1-319 mg/l of CRP from patients with Hodgkin's disease (10), rheumatoid arthritis (10), Crohn's disease (19) and various microbial infections (11), including six with subacute bacterial endocarditis. Since it is likely that CRP does form complexes with its ligands in the plasma these results suggest that complexed CRP is rapidly cleared from the circulation.

Full text

PDF
231

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldo B. A., Fletcher T. C., Pepys J. Isolation of a peptido-polysaccharide from the dermatophyte Epidermophyton floccosum and a study of its reaction with human C-reactive protein and a mouse anti-phosphorylcholine myeloma serum. Immunology. 1977 Jun;32(6):831–842. [PMC free article] [PubMed] [Google Scholar]
  2. De Beer F. C., Pepys M. B. Isolation of human C-reactive protein and serum amyloid P component. J Immunol Methods. 1982;50(1):17–31. doi: 10.1016/0022-1759(82)90300-3. [DOI] [PubMed] [Google Scholar]
  3. De Beer F. C., Pepys M. B. Solid-phase immunoradiometric assay for C-reactive protein using magnetisable cellulose particles. J Immunol Methods. 1982;50(3):299–308. doi: 10.1016/0022-1759(82)90168-5. [DOI] [PubMed] [Google Scholar]
  4. Gotschlich E. C., Liu T. Y. Structural and immunological studies on the pneumococcal C polysaccharide. J Biol Chem. 1967 Feb 10;242(3):463–470. [PubMed] [Google Scholar]
  5. James K., Hansen B., Gewurz H. Binding of C-reactive protein to human lymphocytes. I. Requirement for a binding specificity. J Immunol. 1981 Dec;127(6):2539–2544. [PubMed] [Google Scholar]
  6. James K., Hansen B., Gewurz H. Binding of C-reactive protein to human lymphocytes. II. Interaction with a subset of cells bearing the Fc receptor. J Immunol. 1981 Dec;127(6):2545–2550. [PubMed] [Google Scholar]
  7. Mold C., Du Clos T. W., Nakayama S., Edwards K. M., Gewurz H. C-reactive protein reactivity with complement and effects on phagocytosis. Ann N Y Acad Sci. 1982;389:251–262. doi: 10.1111/j.1749-6632.1982.tb22141.x. [DOI] [PubMed] [Google Scholar]
  8. Narkates A. J., Volanakis J. E. C-reactive protein binding specificities: artificial and natural phospholipid bilayers. Ann N Y Acad Sci. 1982;389:172–182. doi: 10.1111/j.1749-6632.1982.tb22135.x. [DOI] [PubMed] [Google Scholar]
  9. Oliveira E. B., Gotschlich E. C., Liu T. Y. Primary structure of human C-reactive protein. Proc Natl Acad Sci U S A. 1977 Aug;74(8):3148–3151. doi: 10.1073/pnas.74.8.3148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Osmand A. P., Friedenson B., Gewurz H., Painter R. H., Hofmann T., Shelton E. Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins). Proc Natl Acad Sci U S A. 1977 Feb;74(2):739–743. doi: 10.1073/pnas.74.2.739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Pepys J., Longbottom J. L. Antigenic and C-substance activities of related glycopeptides from fungal, parasitic and vegetable sources. Int Arch Allergy Appl Immunol. 1971;41(1):219–221. doi: 10.1159/000230520. [DOI] [PubMed] [Google Scholar]
  12. Pepys M. B. C-reactive protein fifty years on. Lancet. 1981 Mar 21;1(8221):653–657. doi: 10.1016/s0140-6736(81)91565-8. [DOI] [PubMed] [Google Scholar]
  13. Pepys M. B., Dash A. C., Ashley M. J. Isolation of C-reactive protein by affinity chromatography. Clin Exp Immunol. 1977 Oct;30(1):32–37. [PMC free article] [PubMed] [Google Scholar]
  14. Potempa L. A., Siegel J. N., Gewurz H. Binding reactivity of C-reactive protein for polycations. II. Modulatory effects of calcium and phosphocholine. J Immunol. 1981 Oct;127(4):1509–1514. [PubMed] [Google Scholar]
  15. Shine B., de Beer F. C., Pepys M. B. Solid phase radioimmunoassays for human C-reactive protein. Clin Chim Acta. 1981 Nov 25;117(1):13–23. doi: 10.1016/0009-8981(81)90005-x. [DOI] [PubMed] [Google Scholar]
  16. Volanakis J. E. Complement activation by C-reactive protein complexes. Ann N Y Acad Sci. 1982;389:235–250. doi: 10.1111/j.1749-6632.1982.tb22140.x. [DOI] [PubMed] [Google Scholar]
  17. Volanakis J. E., Wirtz K. W. Interaction of C-reactive protein with artificial phosphatidylcholine bilayers. Nature. 1979 Sep 13;281(5727):155–157. doi: 10.1038/281155a0. [DOI] [PubMed] [Google Scholar]
  18. de Beer F. C., Soutar A. K., Baltz M. L., Trayner I. M., Feinstein A., Pepys M. B. Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein. J Exp Med. 1982 Jul 1;156(1):230–242. doi: 10.1084/jem.156.1.230. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES